IDEXX Laboratories, Inc. Stock price

Equities

IDXX

US45168D1046

Medical Equipment, Supplies & Distribution

Delayed Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
539.9 USD +0.07% Intraday chart for IDEXX Laboratories, Inc. +1.47% -2.72%
Sales 2024 * 3.99B Sales 2025 * 4.4B Capitalization 44.86B
Net income 2024 * 928M Net income 2025 * 1.05B EV / Sales 2024 * 11.4 x
Net Debt 2024 * 490M Net Debt 2025 * 292M EV / Sales 2025 * 10.3 x
P/E ratio 2024 *
48.6 x
P/E ratio 2025 *
42.7 x
Employees 11,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 76.42%
More Fundamentals * Assessed data
Dynamic Chart
Idexx Laboratories: Superior growth prospects Our Logo
Idexx Laboratories Insider Sold Shares Worth $790,427, According to a Recent SEC Filing MT
Idexx Laboratories Insider Sold Shares Worth $4,525,596, According to a Recent SEC Filing MT
Transcript : IDEXX Laboratories, Inc. Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-04-2024 11:00 AM
Ancora seeks four board seats at Elanco amid push for changes RE
Transcript : IDEXX Laboratories, Inc. Presents at Bank of America 2024 Animal Health Virtual Summit, Feb-29-2024 10:50 AM
Ancora seeks four board seats at Elanco amid push for changes, sources say RE
ANALYST RECOMMENDATIONS : Coinbase, Fortinet, Nike, Chipotle, Nvidia... Our Logo
Idexx Launches Vellotm, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect CI
Pet products maker Zoetis sees annual profit below estimates on weak demand RE
Idexx Laboratories Insider Sold Shares Worth $6,871,319, According to a Recent SEC Filing MT
Idexx Laboratories Insider Sold Shares Worth $13,295,975, According to a Recent SEC Filing MT
Idexx Laboratories Insider Sold Shares Worth $4,704,559, According to a Recent SEC Filing MT
JPMorgan Adjusts Price Target on IDEXX Laboratories to $630 From $600, Maintains Overweight Rating MT
Morgan Stanley Lifts PT on IDEXX Laboratories to $620 From $600 After 'Impressive' Q4 2023 Upside, 'Solid' 2024 Guide; Overweight Kept MT
More news
1 day+0.07%
1 week+1.47%
Current month-6.14%
1 month-5.55%
3 months-3.07%
6 months+23.56%
Current year-2.72%
More quotes
1 week
524.52
Extreme 524.52
543.33
1 month
524.52
Extreme 524.52
583.39
Current year
507.61
Extreme 507.605
583.39
1 year
372.50
Extreme 372.5
583.39
3 years
317.06
Extreme 317.06
706.95
5 years
168.65
Extreme 168.65
706.95
10 years
56.75
Extreme 56.745
706.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 12-07-31
Director of Finance/CFO 62 03-06-30
Chief Operating Officer - 07-12-31
Members of the board TitleAgeSince
Director/Board Member 71 14-03-10
Director/Board Member 73 12-07-15
Chairman 61 16-10-18
More insiders
Date Price Change Volume
24-03-28 539.9 +0.07% 290,111
24-03-27 539.6 +1.69% 308,904
24-03-26 530.6 +0.17% 398,139
24-03-25 529.7 -0.19% 363,892
24-03-22 530.7 -0.26% 251,360

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
539.9 USD
Average target price
585.8 USD
Spread / Average Target
+8.50%
Consensus
  1. Stock
  2. Equities
  3. Stock IDEXX Laboratories, Inc. - Nasdaq